Bionomics (BNOX) Institutional Ownership $0.19 -0.01 (-4.97%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bionomics (NASDAQ:BNOX)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$3.14MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$164.75K Get BNOX Insider Trade Alerts Want to know when executives and insiders are buying or selling Bionomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNOX Institutional Buying and Selling by Quarter Ad Porter & CompanyRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Bionomics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Lynx1 Capital Management LP599,673$460K0.2%-26.4%7.349% 8/15/2024Armistice Capital LLC1,226,759$941K0.0%N/A15.034% 11/14/2023Lynx1 Capital Management LP815,512$2.20M1.5%N/A9.994% 8/16/2022Woodline Partners LP141,007$986K0.0%-12.4%2.518% 5/6/2022Light Sky Macro LP157,261$1.35M100.0%-19.4%2.808% 2/19/2022Woodline Partners LP161,943$2.03M0.0%N/A2.893% 2/11/2022Light Sky Macro LP195,162$2.45M1.9%N/A3.486% (Data available from 1/1/2016 forward) BNOX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNOX shares? During the previous two years, the following institutional investors and hedge funds held shares of Bionomics shares: Armistice Capital LLC ($941K), Lynx1 Capital Management LP ($460K).Learn more on BNOX's institutional investors. What percentage of Bionomics stock is owned by institutional investors? 15.90% of Bionomics stock is owned by institutional investors. Learn more on BNOX's institutional investor holdings. Which institutional investors have been buying Bionomics stock? The following institutional investors have purchased Bionomics stock in the last 24 months: Armistice Capital LLC ($1.23M), and Lynx1 Capital Management LP ($815.51K). How much institutional buying is happening at Bionomics? Institutional investors have bought a total of 2,042,271 shares in the last 24 months. This purchase volume represents approximately $3.14M in transactions. Which Bionomics major shareholders have been selling company stock? The following institutional investors have sold Bionomics stock in the last 24 months: Lynx1 Capital Management LP ($214.79K). How much institutional selling is happening at Bionomics? Institutional investors have sold a total of 214,794 shares in the last 24 months. This volume of shares sold represents approximately $164.75K in transactions. Related Companies FBRX Institutional Ownership VCNX Institutional Ownership ADIL Institutional Ownership ONVO Institutional Ownership PRTG Institutional Ownership MBRX Institutional Ownership ERNA Institutional Ownership CDIO Institutional Ownership BCDA Institutional Ownership JAGX Institutional Ownership This page (NASDAQ:BNOX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.